Table 1.
FABP‐4, ng/mL (N=4026) | ||||
---|---|---|---|---|
≤22.36 | >22.36 to 29.92 | >29.92 to 40.64 | >40.64 | |
n | 1008 | 1009 | 1009 | 1000 |
FABP‐4, ng/mL | 18.0 | 26.2 | 34.7 | 58.1 |
Age, y | 74.6±4.9 | 74.6±5.2 | 74.7±5.4 | 74.8±5.3 |
Male | 72.2% | 44.4% | 25.0% | 13.0% |
Black | 13.4% | 15.6% | 16.7% | 21.5% |
Field center | ||||
North Carolina | 26.2% | 28.1% | 28.8% | 22.3% |
California | 26.4% | 28.9% | 23.9% | 29.1% |
Maryland | 19.0% | 18.9% | 21.7% | 23.8% |
Pennsylvania | 28.4% | 24.0% | 25.6% | 24.8% |
Body mass index, kg/m2 | 24.5±3.5 | 26.0±3.9 | 27.2±4.1 | 29.9±5.7 |
Waist circumference, cm | 92.0±10.7 | 95.5±12.1 | 97.9±12.3 | 104.1±15.5 |
Systolic BP, mm Hg | 134.9±20.9 | 135.3±20.7 | 136.6±21.2 | 138.4±21.7 |
Diastolic BP, mm Hg | 72.0±11.3 | 71.6±11.0 | 71.8±10.8 | 70.8±12.0 |
Heart rate | 63.4±10.8 | 65.2±10.4 | 65.9±10.3 | 68.1±11.6 |
Grip strength, kg | 32.8±10.7 | 28.2±9.7 | 25.3±8.9 | 23.7±7.6 |
LDL‐cholesterol, mg/dL | 114.8±31.4 | 119.0±32.4 | 122.7±33.7 | 123.4±37.0 |
Triglycerides, mg/dL | 116.5±66.8 | 134.1±73.5 | 148.4±82.8 | 167.2±93.9 |
HDL‐cholesterol, mg/dL | 53.8±14.7 | 54.5±15.0 | 54.8±14.3 | 53.2±13.9 |
C‐reactive protein, mg/L | 3.9±9.8 | 4.5±7.1 | 5.0±8.9 | 7.8±12.2 |
Fibrinogen, mg/dL | 311.5±62.2 | 323.0±62.2 | 325.9±62.8 | 349.4±75.5 |
eGFRcys | 81.5±16.9 | 76.8±16.8 | 73.2±17.3 | 63.6±17.9 |
Alcoholic beverages/wk | 3.1±6.4 | 2.3±5.3 | 1.8±5.4 | 1.3±7.9 |
Total physical activity, kcal | 1864.6±2047.7 | 1496.0±1783.0 | 1401.8±1710.5 | 1033.7±1332.9 |
Antihypertensive medication | 34.6% | 42.8% | 48.4% | 60.8% |
Prevalent diabetes mellitus | 10.4% | 12.0% | 13.4% | 19.3% |
Smoking status | ||||
Never | 37.7% | 42.7% | 53.3% | 53.5% |
Former | 51.2% | 45.6% | 37.2% | 38.3% |
Current | 11.1% | 11.7% | 9.5% | 8.2% |
Self‐reported health | ||||
Excellent | 9.4% | 7.9% | 7.6% | 4.0% |
Very good | 38.0% | 35.1% | 31.5% | 26.0% |
Good | 38.3% | 40.5% | 43.4% | 44.6% |
Fair | 13.2% | 15.0% | 16.7% | 22.2% |
Poor | 1.1% | 1.5% | 0.8% | 3.1% |
BP indicates blood pressure; CHS, Cardiovascular Health Study; CVD, cardiovascular disease; FABP‐4, fatty acid binding protein‐4; eGFR, estimated glomerular filtration rate; HDL, high‐density lipoprotein; and LDL, low‐density lipoprotein.